Last week at the 23andMe headquarters, over 100 researchers gathered together for the company’s annual Genome Research Day.
Scientists have located sections of DNA that appear to play a role in controlling whether an individual’s skin burns or tans, which has laid the groundwork for genetic tests that could predict people’s responses to sunlight.
George Church’s idea is to “have the body and mind of a 22-year-old but the experience of a 130-year-old,” and himself might be one of the first volunteers to try the approach in humans.
Color Genomics unveils its plan to give people a peek into their genetic risk, by offering a test for hereditary cancer and high cholesterol. But, they are offering more than just that.
Technologies for amplifying, sequencing and matching DNA have created new opportunities in genomic science. But there are ethical and social implications.
The National Insitute of Health is finally launching All of Us, a huge research study with the aim of making precision medicine available to people of all backgrounds. But will people give up their data?
Researchers at the Broad Institute of MIT and Harvard have reported that their platform, SHERLOCK, now can be used to detect viruses directly in clinical samples such as blood or saliva.
Biotech startup Mammoth Biosciences launches a CRISPR powered search engine that ‘works like Google’ for disease detection.
23andMe has provided their customers with a new health portal that makes it possible to share how they manage 18 common health conditions, including depression, ADHD, migraine and asthma.
With the demand for direct-to-consumer genetic tests on the rise, a new analysis has questioned how reliable the results really are.